Fluoroquinolone-Containing Third-Line Regimen against Mycobacterium tuberculosis In Vivo

The objective of the present study was to compare the activities of a third-line regimen recommended by the World Health Organization (WHO) and two derivatives of that regimen with the activity of the standard combination of isoniazid, rifampin, and pyrazinamide as a positive control against Mycobac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Veziris, Nicolas, Truffot-Pernot, Chantal, Aubry, Alexandra, Jarlier, Vincent, Lounis, Nacer
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2003
Konular:
Experimental Therapeutics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC201131/
https://ncbi.nlm.nih.gov/pubmed/14506018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.10.3117-3122.2003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller